Your browser doesn't support javascript.
loading
AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivo.
Cobos Jiménez, Viviana; Geretz, Aviva; Tokarev, Andrey; Ehrenberg, Philip K; Deletsu, Selase; Machmach, Kawthar; Mudvari, Prakriti; Howard, J Natalie; Zelkoski, Amanda; Paquin-Proulx, Dominic; Del Prete, Gregory Q; Subra, Caroline; Boritz, Eli A; Bosque, Alberto; Thomas, Rasmi; Bolton, Diane L.
Affiliation
  • Cobos Jiménez V; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Geretz A; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
  • Tokarev A; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Ehrenberg PK; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
  • Deletsu S; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Machmach K; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
  • Mudvari P; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Howard JN; George Washington University, Washington, DC, USA.
  • Zelkoski A; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Paquin-Proulx D; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
  • Del Prete GQ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Subra C; George Washington University, Washington, DC, USA.
  • Boritz EA; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Bosque A; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
  • Thomas R; US Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
  • Bolton DL; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
iScience ; 26(10): 108015, 2023 Oct 20.
Article in En | MEDLINE | ID: mdl-37860759
ABSTRACT
Persistent HIV-1 reservoirs of infected CD4 T cells are a major barrier to HIV-1 cure, although the mechanisms by which they are established and maintained in vivo remain poorly characterized. To elucidate host cell gene expression patterns that govern virus gene expression, we analyzed viral RNA+ (vRNA) CD4 T cells of untreated simian immunodeficiency virus (SIV)-infected macaques by single-cell RNA sequencing. A subset of vRNA+ cells distinguished by spliced and high total vRNA (7-10% of reads) expressed diminished FOS, a component of the Activator protein 1 (AP-1) transcription factor, relative to vRNA-low and -negative cells. Conversely, FOS and JUN, another AP-1 component, were upregulated in HIV DNA+ infected cells compared to uninfected cells from people with HIV-1 on suppressive therapy. Inhibiting c-Fos in latently infected primary cells augmented reactivatable HIV-1 infection. These findings implicate AP-1 in latency establishment and maintenance and as a potential therapeutic target to limit HIV-1 reservoirs.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2023 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IScience Year: 2023 Document type: Article Affiliation country:
...